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AbstrACt
Introduction Transparency and completeness of health 
research is highly variable, with important deficiencies in 
the reporting of methods and results of studies. Reporting 
guidelines aim to improve transparency and quality of 
research reports, and are often developed by consortia of 
journal editors, peer reviewers, authors, consumers and 
other key stakeholders. The objective of this study will be 
to investigate the characteristics of scientific collaboration 
among developers and the citation metrics of reporting 
guidelines of health research.
Methods and analysis This is the study protocol for a 
cross-sectional analysis of completed reporting guidelines 
indexed in the Enhancing the QUAlity and Transparency Of 
health Research Network Library. We will search PubMed/
MEDLINE and the Web of Science. Screening, selection and 
data abstraction will be conducted by one researcher and 
verified by a second researcher. Potential discrepancies 
will be resolved via discussion. We will include published 
papers of reporting guidelines written in English. Published 
papers will have to meet the definition of a reporting 
guideline related to health research (eg, a checklist, flow 
diagram or explicit text), with no restrictions by study 
design, medical specialty, disease or condition. Raw data 
from each included paper (including title, publication year, 
journal, subject category, keywords, citations, and the 
authors’ names, author’s affiliated institution and country) 
will be exported from the Web of Science. Descriptive 
analyses will be conducted (including the number of 
papers, citations, authors, countries, journals, keywords 
and main collaboration metrics). We will identify the most 
prolific authors, institutions, countries, journals and the 
most cited papers. Network analyses will be carried out to 
study the structure of collaborations.
Ethics and dissemination No ethical approval will be 
required. Findings from this study will be published in 
peer-reviewed journals. All data will be deposited in a 
cross-disciplinary public repository. It is anticipated the 
study findings could be relevant to a variety of audiences.
IntroduCtIon  
Many published reports of health research 
studies lack clarity and transparency on how 
they were conducted and what they found. If 
published reports do not provide sufficient 
details about which questions were addressed, 
or lack descriptions of study conduct and 
analyses, research users may be left with an 
incomplete picture of what has been done; 
and the reliability of the findings cannot be 
interpreted correctly. Studies of the biomed-
ical literature have shown that the quality of 
research is highly variable, with important 
deficiencies in the reporting of methods and 
results of health research studies.1–11 Unless 
research is adequately reported, investments 
are wasted because research findings are 
unusable.12–15 To help improve this situa-
tion, the scientific community needs close 
collaborations between journal editors, peer 
reviewers, authors, consumers and other key 
stakeholders.16–18 
strengths and limitations of this study
 ► To our knowledge, this will be the first attempt to 
systematically map and describe the characteristics 
of scientific collaboration among developers and 
the citation metrics of reporting guidelines of health 
research.
 ► We will not restrict inclusion based on the focus (eg, 
study design or medical specialty) of the reporting 
guideline and will be able to collect data on a broad 
cross-section of guidelines for reporting health 
research.
 ► Although the Enhancing the QUAlity and Transparency 
Of health Research Network Library is regularly up-
dated based on comprehensive searches across the 
main databases indexing health-related literature, 
it cannot be ruled out that we will potentially miss 
some published reporting guidelines.
 ► A potential limitation could be the study will include 
only reporting guideline papers catalogued in one 
database and written in English.
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Reporting guidelines of health research aim to improve 
transparency and quality of research reports. Reporting 
guidelines for health research (such as the Consoli-
dated Standards of Reporting Trials (CONSORT) state-
ment,19 20 the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) statement,21 22 the 
Standards for Reporting of Diagnostic Accuracy (STARD) 
guidelines,23 the Strengthening the Reporting of Obser-
vational Studies in Epidemiology (STROBE) statement24 
and the Animal Research: Reporting of In Vivo Experi-
ments (ARRIVE) guidelines25) have been widely dissemi-
nated through publications in high-impact factor medical 
journals and endorsements by editors, peer reviewers and 
authors.26 27 In June 2008, the Enhancing the QUAlity 
and Transparency Of health Research (EQUATOR) 
Network was officially launched as a global collaborative 
initiative seeking to improve the value and reliability of 
published health research by promoting transparent and 
accurate reporting and wider use of high-quality, robust 
reporting guidelines. As part of its resource develop-
ment, the EQUATOR Network’s website (http://www. 
equator- network. org/) contains a comprehensive and 
up-to-date searchable database (‘the EQUATOR Network 
Library’) of reporting guidelines (completed and under 
development) relevant to health research,28 29 tools and 
instruments for better reporting aimed at different users 
and information about relevant educative activities and 
events.
Previous reviews have focused on the characteristics 
and methods for developing reporting guidelines,28–30 
and the completeness of reporting health research in 
different areas.6–9 31–34 However, to the best of our knowl-
edge, there has been no specific study focusing on the 
characterisation of research collaborations among devel-
opers of reporting guidelines for health research studies.
The objective of this study will be to investigate the 
characteristics of scientific collaboration and citation 
metrics of reporting guidelines of health research. Partic-
ularly, we will map the EQUATOR Network Library to: 
(1) identify reporting guidelines and key actors (authors, 
institutions, countries and journals) producing and 
disseminating them, and (2) to describe production, cita-
tions and collaboration patterns in the area.
MEthods And AnAlysIs
design
This is the study protocol for a cross-sectional anal-
ysis of reporting guidelines indexed in the web-based 
EQUATOR Network Library. The EQUATOR Network 
Library provides an up-to-date online collection of guide-
lines and policy documents related to health research 
reporting. These reporting guidelines are aimed mainly 
at authors of research papers, journal editors, peer 
reviewers, reporting guideline developers, educators and 
research funders. At present, more than 300 guidelines 
and related documents are available on the EQUATOR 
Network website (http://www. equator- network. org/ 
library/). The EQUATOR Network Library provides a 
searchable database of all reporting guidelines (published 
since 1996) identified through systematic literature 
searches that focus on/provide specific guidance for 
reporting of various types of research designs, compo-
nents of research reports or specific medical conditions 
or procedures. The EQUATOR Network Library provides 
guidance for different types of health research studies, 
for example, experimental studies including randomised 
trials (eg, CONSORT statement19 20), systematic reviews 
and meta-analyses (eg, PRISMA statement21 22), diag-
nostic and prognostic studies (eg, STARD guidelines23 
and Transparent Reporting of a multivariable predic-
tion model for Individual Prognosis Or Diagnosis 
statement35 36), observational studies (eg, STROBE 
statement24), economic evaluations (eg, Consolidated 
Health Economic Evaluation Reporting Standards state-
ment37), case reports (eg, CAse REport guidelines38 39), 
study protocols (eg, Standard Protocol Items: Recom-
mendations for Interventional Trials statement40 and 
PRISMA-Protocols41 42), animal preclinical research (eg, 
ARRIVE guidelines25) and other reporting guidelines 
(eg, mixed-methods studies, reliability and agreement 
studies and clinical practice guidelines). In addition to 
these reporting guidelines, the EQUATOR Network 
Library lists guidance that relates to publication of health 
research for sections of research reports (eg, Statistical 
Analyses and Methods in the Published Literature for 
statistical methods and analysis43), guidance for specific 
medical conditions, procedures or clinical areas (eg, 
cardiovascular medicine, clinical oncology, paediatrics, 
public health or genetics), but also reporting guidelines 
under development. Currently, the EQUATOR Network 
Library website lists only references to journals that 
published the reporting guideline first, not later repub-
lications (often in a national or local journal, usually in a 
local language edition).29
Eligibility criteria
To be eligible for inclusion, published papers will have 
to meet the following definition of a reporting guide-
line related to health research: ‘A reporting guideline 
is a checklist, flow diagram or explicit text to guide 
authors in reporting a specific type of research, devel-
oped using explicit methodology’.26 27 We will include 
reporting guidelines with no restrictions by study 
design, medical specialty, disease or condition. We will 
include published papers of reporting guidelines (ie, 
‘completed’ reporting guidelines) written in English. 
Translations of any existing reporting guideline in other 
non-English languages will be excluded (eg, CONSORT 
translation into Spanish or Chinese). Meeting abstracts, 
proceedings paper (journals, book based), editorials, 
book chapters, corrections, retracted publications and 
other items (eg, data paper, news and notes) will be 
excluded. Reporting guidelines under development will 
be also excluded.
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searching
To provide a reliable summary of the reporting guide-
line literature, we will search for completed reporting 
guidelines indexed in the EQUATOR Network Library 
from inception to 31 July 2018 (this date will represent 10 
years after the official launch of the EQUATOR Network 
in 200844). We will first identify all the published papers 
catalogued in the EQUATOR Network Library. For all 
reporting guidelines, an information scientist will obtain 
from the EQUATOR website the following: the title 
(or reference), standard identifier for each paper (eg, 
PubMed ID or a digital object identifier, if the paper has 
one), study design and date of record last updated. Addi-
tionally, we will contact the EQUATOR Network Library 
team for clarifications and further data (if necessary). 
To ensure consistency in the searching process, a second 
researcher will perform complementary hand-searches 
(eg, websites of reporting guidelines catalogued in the 
EQUATOR Network Library) (see examples in table 1) 
to check for potential indexing omissions or errors. We 
will use all the standard identifiers retrieved for published 
papers to carry out a search in PubMed/MEDLINE in 
order to have access to full references, titles and abstracts. 
With this information, we will perform a search of the 
Web of Science (Clarivate Analytics, Philadelphia, Penn-
sylvania, USA) based on the title or the standard iden-
tifiers of the papers. Intended date for the searches in 
PubMed/MEDLINE and Web of Science will be 15 April 
2019. The search results will be imported into a Microsoft 
Access (Microsoft, Seattle, Washington , USA) database.
screening and selection
All titles and abstracts will be screened against our eligi-
bility criteria by one researcher and verified by a second 
researcher. We will retrieve the full text of any paper(s) 
meeting our eligibility criteria or for which eligibility 
remains unclear. Any discrepancies in the screening of 
titles and abstracts and selection of full-text papers will be 
resolved via discussions by the research team, if necessary.
data extraction and data normalisation
Raw data from each paper will be exported (downloaded 
online) from the Web of Science (Clarivate Analytics) by 
one researcher (senior information specialist). Data will 
be collected in Microsoft Access (Microsoft) containing 
the following: title, publication year, journal, subject cate-
gory, keywords, citations (the number of times a paper 
has been cited by other publications), source, language, 
document type (eg, article or review according to Docu-
ment Type Field from the Web of Science) and the 
authors’ names, author’s affiliated institution (eg, institu-
tion name, department and institution address including 
city), and country. All data will be verified by a second 
researcher to minimise potential omissions or informa-
tion errors. Any discrepancies in the extracted data will 
be resolved via discussion or adjudication by a third 
researcher if necessary.
To ensure consistency in the data extraction, a process 
of data cleaning and normalisation will be conducted by 
two members of the research team to bring together the 
different names of an author, institution, country, journal 
and keywords. Specifically, one researcher will check the 
names by which an individual author appeared in two or 
more different forms (eg,  ‘Douglas G Altman’ or ‘Douglas 
Altman’ or ‘Doug Altman’), using coincidence in that 
author’s affiliated institution as the basic criterion for 
normalisation (eg, Oxford University, UK). In the case of 
author’s affiliated institution, names in many records may 
include two or more institutions (eg, university hospi-
tals, research centres and academic institutions).45 So, 
we will proceed to distinguish between institution names 
by recording all variations of any individual macroinsti-
tution as could be identified for each record (eg, for the 
institutional address ‘The Ottawa Hospital and Univer-
sity of Ottawa, Canada’, the normalisation approach will 
be to present ‘University of Ottawa, Canada’ separately 
from ‘The Ottawa Hospital, Canada’). Missing data (eg, 
missing country information of an affiliated institution) 
will be substituted and completed by manual web search.
Keywords (‘author keywords’ and ‘keyword plus’) 
which are automatically assigned by the Web of Science 
(Clarivate Analytics) from the title of the paper will be 
extracted and used to represent the conceptual content 
of the publications.
Typographical, transcription and/or indexing errors 
will be corrected or removed. All potential discrepancies 
will be resolved via discussion.
data analysis
The analysis will be descriptive, with data summarised as 
frequencies and percentages for categorical variables or 
median and IQR for continuous variables.
Our primary analysis of production, citations and 
collaboration patterns will be based on single papers 
(paper-level analysis). The description of the scientific 
production and citation impact will be carried for authors, 
institutions, countries and journals (eg, total number of 
papers and total number of citations). Tables will be used 
to present the most prolific authors (5 or more published 
papers), institutions (5 or more papers), countries (10 or 
more papers), journals (10 or more papers) and the most 
cited papers and reporting guidelines (‘top 50 citation 
classics’).
We will describe collaboration patterns with respect to 
authors, institutions and countries: number of signatures 
(total number of authors included in all the papers of 
each author), number of collaborators (and main collab-
orators in terms of number of collaborations), number 
of papers with coauthors, collaborations between authors 
(‘interindividual collaboration’), and collaboration index 
which is the mean number of signatories per paper. We 
will identify collaborations between institutions (‘interin-
stitutional collaboration’) and countries (‘international 
collaboration’). For institutions, we will differentiate 
between institutional collaborations in the same country 
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(‘domestic interinstitutional collaboration’) and institu-
tional collaborations from different countries (‘interna-
tional interinstitutional collaboration’).
Network analyses46–48 will be carried to study the struc-
ture of collaborations between authors, institutions and 
countries. Collaboration networks will be constructed 
by identifying the regularities in the patterning of 
relationships among entities (eg, which might be authors, 
institutions and countries) for each single paper. We will 
present network diagrams to illustrate the structure of 
scientific collaborations. A network diagram is a visual 
representation of a collection of nodes or vertices (eg, 
authors) and the relational ties connecting them, called 
links or edges (eg, numbers of papers or collaborations). 
Table 1 Examples of websites for complementary hand-searches
Guideline developer(s) group Relevant URL
AGREE http://www.agreetrust.org/resource-centre/agree-reporting-checklist/
ARRIVE—National Centre for the Replacement 
Refinement and Reduction of Animals in Research 
https://www.nc3rs.org.uk/arrive-guidelines
CARE statement https://www.care-statement.org/
CHEERS statement—International Society for 



























Last search of URLs in 2 January 2019.
 AGREE, Appraisal of Guidelines for Research and Evaluation; ARRIVE, Animal Research: Reporting of In Vivo Experiments; CARE, CAse 
REport; CHEERS, Consolidated Health Economic Evaluation Reporting Standards; CIRCLe SMT, Consensus on Interventions Reporting 
Criteria List for Spinal Manipulative Therapy; CORE, Clarity and Openness in Reporting; CONSORT, Consolidated Standards of Reporting 
Trials; EQUATOR, Enhancing the QUAlity and Transparency Of health Research; GATHER, Guidelines for Accurate and Transparent 
Health Estimates Reporting; MORECare, Methods of Researching End of life Care; ORION, Outbreak Reports and Intervention Studies 
of Nosocomial Infection; PROCESS, Preferred Reporting of Case Series in Surgery; PRISMA, Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses; REFLECT, Reporting Guidelines for Randomised Controlled Trials for Livestock and Food Safety; RIGHT, 
Essential Reporting Items for Practice Guidelines in Healthcare; RRID, Resource Identification Initiative; SCARE, Surgical Case Reports 
Guidelines; SCRIBE, Single-Case Reporting Guideline in Behavioural Interventions; SPIRIT, Standard Protocol Items: Recommendations 
for Interventional Trials; SQUIRE, Standards for Quality Improvement Reporting Excellence; STROCSS, Strengthening the Reporting of 
Cohort Studies in Surgery; STARD, Standards for Reporting of Diagnostic Accuracy; STROBE, Strengthening the Reporting of Observational 
Studies in Epidemiology; TREND, Transparent Reporting of Evaluations with Non-randomised Designs; TRIPOD, Transparent Reporting of a 
multivariable prediction model for Individual Prognosis Or Diagnosis. 
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Particularly, we will identify clusters of more intense 
collaboration networks by applying a priori thresholds 
(‘collaboration intensity’) based on the numbers of 
papers signed in collaboration between authors (5 or 
more papers), institutions (5 or more papers) and coun-
tries (10 or more papers). All the network diagrams will 
be presented as undirected-weighted graphs (where node 
sizes are proportional to the number of papers, links are 
bidirectional, and the link thicknesses are proportional 
to the number of collaborations). Key standard measures 
and metrics for quantifying network structure (centrality 
measures such as ‘degree of centrality’, ‘closeness’ and 
‘betweenness)49 50 will also be calculated to complement 
the cluster analysis. Centrality measures identify the most 
prominent (‘key’) members of a scientific community, 
that is, those who are extensively involved in relationships 
with other network members. Degree of centrality51 52 is a 
simple centrality measure that counts how many connected 
links a node has (eg, the number of coauthors of a given 
author). If a node has many ties compared with nodes, 
this indicates that this node has a central position in the 
network. In a collaboration network, it seems reasonable 
to suppose that a node (eg, author) having connections 
to many others might have more activity or more prestige 
than those having fewer connections. Centrality can also 
characterise the shape of a whole network. Closeness46 48 
is based on the notion of distance. Closeness measures 
the mean distance from a node to other nodes (eg, an 
author that has high centrality closeness is likely to receive 
information more quickly than others in the network). 
Closeness measures efficiency or independence. Between-
ness46 52 measures the extent to which a node (eg, author) 
lies on paths between other nodes or how much a node 
connects other nodes with each other (eg, an author who 
is high in betweenness is able to control the flow of infor-
mation or resources passing between other coauthors).
We will conduct topical (also called linguistic, semantic 
or textual) data analyses and visualisations to determine 
the topic coverage of a body of text. The most frequently 
used keywords will be identified and presented for each 
journal. Word clouds displaying the frequency of terms 
(with larger words depicting the frequency of occurrence) 
will be generated for the main keywords to identify major 
topics. We will also present the ‘co-words network’ of 
keywords representing the co-occurrence phenomenon 
of highly frequent words in the papers.53
Multiple publication of identical paper(s)
It is important to note that for a paper presenting a 
reporting guideline may have been published simulta-
neously by multiple journals to support wider dissemi-
nation and uptake.26 Some of these reporting guidelines 
published in multiple journals include CONSORT state-
ment19 20 and PRISMA statement.21 22 Secondary analysis 
will consider and characterise production, citations and 
collaboration patterns by integrating data for multiple 
(identical) papers of a single reporting guideline (guide-
line-level analysis). This will involve the following: (1) 
authorship and collaboration data will be counted once 
and (2) citation impact will be computed by grouping the 
total number of citations across the multiple (identical) 
papers published in different journals.
Additional analyses
We will undertake a subgroup analysis to compare papers 
and reporting guidelines in terms of scientific produc-
tivity, citation and collaboration patterns before and after 
the official launch of the EQUATOR Network in 200844: 
‘before 2008 (pre-EQUATOR Network)’ versus ‘after 
2008 (post-EQUATOR Network)’.
Depending on the productivity and collaboration 
patterns, we plan to explore whether sensitivity anal-
yses related to thresholds (‘collaboration intensity’) are 
feasible using different numbers of papers in collabora-
tion (eg, between authors, institutions and countries) to 
see how stable our results are.
software considerations
Relational structure (network) visualisations and metrics 
will be produced by using PAJEK (University of Ljubljana, 
Slovenia),54 a free software package for large network 
analyses. Word clouds will be drawn using Wordle,55 a 
free online tool, for graphical representation of words 
frequency. We also plan to explore additional visualisation 
tools, considering this is a constantly evolving field.56–58
Patient and public involvement
No patients and/or public were involved in setting the 
research question, nor were they involved in devel-
oping plans for design (or implementation) of this 
study protocol. No patients and/or public will be asked 
to advise on the interpretation or writing up of results. 
There are no specific plans to disseminate the results of 
the research to the patient community.
Ethics and dissemination
To the best of our knowledge, this cross-sectional analysis 
will be the first attempt to systematically map the content 
of the EQUATOR Network Library using methods and 
tools from network science.46–48 The study will serve to 
identify reporting guidelines of health research, key actors 
producing and disseminating them, citation impact and 
scientific collaborations in the area. It will be helpful to 
determine the most intense collaboration patterns, most 
productive authors, institutions and countries developing 
reporting guidelines, most prolific journals disseminating 
them and the ‘citation classics’ of guidelines for reporting 
health research studies.
 Any amendments made to this protocol when 
conducting the analyses will be outlined and reported 
in the final manuscript. Findings from this study will be 
published in peer-reviewed journals. All data underlying 
the findings reported in the final manuscript will be 
deposited in a cross-disciplinary public repository, such 
as the Open Science Framework (https:// osf. io/) or 
Zenodo (https:// zenodo. org/).
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We anticipate the study could be relevant to a variety 
of audiences including journal editors, peer reviewers, 
research authors, guideline developers, research 
funders, educators and other potential key stakeholders. 
Moreover, the study findings could further be used to 
strengthen scientific capacity for international, national 
and subnational collaborations in order to increase value 
and reduce waste from incomplete or unusable reports of 
health research studies.12 15
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